Valsartan NDC 72336-910

NDC codes

FDA NDC Directory

Product NDC (as listed)72336-910Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72336-0910Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72336-910-79	72336091079	120 mL in 1 BOTTLE, PLASTIC (72336-910-79)Marketed from Apr 4, 2022
72336-910-89	72336091089	473 mL in 1 BOTTLE, PLASTIC (72336-910-89)Marketed from Apr 4, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Valsartan
Generic name (nonproprietary): valsartan
Active ingredients: Valsartan — 4 mg/mL
Dosage form: Solution
Route: Oral
Labeler: Lifsa Drugs LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214102
Marketing start: Apr 4, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 72336-910_dd4cbd3f-572e-400b-8fe7-98d537557b80SPL ID dd4cbd3f-572e-400b-8fe7-98d537557b80SPL set ID 130e1659-9c2d-49ca-9db8-d28aa23fd133RxCUI 1996254UNII 80M03YXJ7I
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472336091079 followed by a unit qualifier and the quantity

Package 72336-0910-79. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 7, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

Valsartan is an angiotensin II receptor blocker (ARB) indicated for: Hypertension in adults and children six years and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions (1.1) Heart failure (NYHA class II-IV); Valsartan oral solution significantly reduces hospitalization for heart failure in patients who are unable to swallow valsartan tablets (1.2) Stable left ventricular failure or left ventricular dysfunction following myocardial infarction; Valsartan oral solution reduces cardiovascular mortality in patients who are unable to swallow valsartan tablets (1.3) 1.1 Hypertension Val…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214102

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214102
Product	Strength	Form · route	Labeler	Product NDC
Valsartan	Valsartan 4 mg/mL	SolutionOral	ANI Pharmaceuticals, Inc.	70954-310